Ajim Tamboli

Ajim Tamboli

No más puestos en curso
49 años
Finance
Health Technology
Consumer Services

Perfil

Ajim Akbar Tamboli is currently Chief Financial Officer at First Tracks Biotherapeutics, Inc. since 2026.
Formerly, served as Chief Financial Officer at Monte Rosa Therapeutics, Inc. from 2020 to 2023, at Rodin Therapeutics, Inc. from 2019 to 2020, and at ADARx Pharmaceuticals, Inc. Held the position of Analyst at Asymmetry Capital Management LP from 2018 to 2019 and at Columbia Management Investment Advisers LLC from 2010 to 2013.
Worked as Senior Portfolio Manager at Hovan Capital Management LLC from 2008 to 2009.
Was Research Analyst at Lehman Brothers, Inc. from 2003 to 2007 and Consultant at Duquesne Capital Management LLC in 2002.
Served as Equity Research Analyst at Credit Suisse Securities (USA) LLC (Broker) from 2000 to 2001.
Also held the role of Partner & Analyst at Endurant Capital Management LP.
Education includes undergraduate degree in 1998 and graduate degree in 2002 from the University of Pennsylvania.

Cargos activos de Ajim Tamboli

EmpresasCargoInicio

Antiguos cargos conocidos de Ajim Tamboli.

EmpresasCargoFin
MONTE ROSA THERAPEUTICS, INC. Director Financiero/CFO 08/08/2023
Director Financiero/CFO 01/01/2020
Analyst-Equity 01/01/2019
Analyst-Equity 01/07/2013
Analyst-Equity 01/12/2009
Ver el detalle de la experiencia de Ajim Tamboli.

Formación de Ajim Tamboli.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

96

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Finance

Finance

Finance

Finance

Consumer Services

Finance

Health Technology

Finance

Finance

Commercial Services

Health Technology

-40%: Ampliación de plazo extraordinaria
d
:
:
APROVECHAR LA PROMOCIÓN